The median resistin mRNA levels in DM-ILD were 0.014 (0.006–0.038), which was significantly higher than that in DM patients without ILD [0.008 (0.004–0.013)] and HCs [0.005 (0.004–0.014)] (p = 0.043, 0.014, respectively) (Figure 1A). The gene discussed is RETN; the disease is dermatomyositis.